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Abstract  
Peptides derived from apolipoprotein A-I (apoA-I), the main component of high-
density lipoprotein (HDL), constitute the main component of amyloid deposits that 
co-localise with atherosclerotic plaques. Here we investigate the molecular details of 
full-length, lipid-deprived apoA-I after assembly into insoluble aggregates under 
physiologically-relevant conditions known to induce aggregation in vitro.  Unmodified 
apoA-I is shown to remain soluble at pH 7 for at least 3 days, retaining its native α-
helical-rich structure. Upon acidification to pH 4, apoA-I rapidly assembles into 
insoluble non-fibrillar aggregates lacking the characteristic cross-beta features of 
amyloid. In the presence of heparin, the rate and thioflavin T responsiveness of the 
aggregates formed at pH 4 increase and short amyloid-like fibrils are observed, 
which give rise to amyloid-characteristic X-ray reflections at 4.7 and 10 Å. Solid-state 
NMR (SSNMR) and synchrotron radiation circular dichroism (SRCD) spectroscopy of 
fibrils formed in the presence of heparin retain some α-helical characteristics 
together with new β-sheet structures. Interestingly, SSNMR indicates a similar 
molecular structure of aggregates formed in the absence of heparin at pH 6 after 
oxidation of the three methionine residues, although their morphology is rather 
different from the heparin-derived fibrils. We propose a model for apoA-I aggregation 
in which perturbations of an 4-helix bundle-like structure, induced by interactions of 
heparin or methionine oxidation, cause the partially helical N-terminal residues to 
disengage from the remaining, intact helices, thereby allowing self-assembly via β-
strand associations.  
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Atherosclerosis is a disease of the circulatory system initiated by the formation of 
plaques lining the arterial vessels composed of fibrous protein, cholesterol and 
extracellular matrix elements. Excess cholesterol, which can promote formation of 
these plaques, is removed from the circulatory system and transported to the liver for 
processing by the high-density lipoprotein (HDL) complex.1, 2 The anti-atherogenic 
properties of HDL are attributed to their ability to stimulate cellular cholesterol efflux 
through the transport of cholesterol from the atherosclerotic lesions to the liver, as 
well as to inhibit low-density lipoprotein (LDL) oxidation and inflammatory events.2  
The main protein component of HDL is the 28-kDa, 243-residue apolipoprotein A-I 
(apoA-I), which accumulates cholesterol and phospholipids 3 and has high structural 
plasticity, adopting different conformational structures depending on whether it is 
lipid-deprived or associated with HDL particles. The lipid-deprived protein has a core 
4-helix bundle-like structure and lipid-bound apoA-I forms a tetrameric twisted-ring of 
mostly of α-helices occasionally broken up by proline.4-9 ApoA-I maintains the HDL 
structure and integrity by forming an anti-parallel helical double belt surrounding the 
lipids and cholesterol. About 95% of circulating plasma apoA-I exists as a stable α-
helical conformation associated with HDL with the remainder in a labile lipid-deprived 
monomeric state.10 
Lipid-deprived apoA-I variants can undergo an alternative folding pathway in 
which the protein self-assembles into β-sheet rich amyloid fibrils,11, 12 resulting in loss 
of the HDL’s atheroprotective mechanism, the accumulation of damaging plaques in 
vital organs and, potentially, excessive inflammation that has been shown to be 
induced by cytotoxic fibril intermediates.13, 14 Hereditary forms of apoA-I amyloidosis 
are characterized pathologically by the deposition of 80-100 residue N-terminal 
peptide fragments derived from apoA-I mutants.15-17  Several natural single point 
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mutations have been identified in the protein’s N-terminal region and residues 170-
17814, 15, 18 and some, if not all, of these mutations destabilize the three-dimensional 
structure and ultimately expose regions to proteolytic cleavage.19 Various N-terminal 
peptides have been shown to assemble into amyloid-like fibrils and bind the 
thioflavin T dye in vitro autonomously in the absence of the remaining apoA-I 
sequence.20-22 A non-hereditary, acquired form of amyloidosis involving non-variant 
apoA-I has also been identified and is a common feature of lesions in 
atherosclerosis.12, 23, 24 The atherosclerotic plaques incorporate full-length non-
variant protein in addition to N-terminal peptide fragments.12, 25, 26  A 100-fold 
increase in the amount of apoA-I in atherosclerotic arteries compared with normal 
arteries has been observed, and the protein deposits are fibrillar and cross-linked.27, 
28 The high incidence of fibrillar apoA-I associated with atherosclerotic lesions, along 
with their cytotoxicity and ability to activate arterial macrophages, suggest that 
amyloid deposition may decrease plaque stability and contribute to the progression 
of atherosclerosis.14, 26, 29, 30  
The mechanism by which the native apoA-I assembles into the aggregates 
associated with atherosclerosis is not known, but studies of ApoA-I self-assembly in 
vitro suggest that the process is accelerated by three factors. Aggregation is more 
rapid under acidic conditions, which is consistent with the local decrease in 
extracellular pH under inflammation and in chronic hypoxic conditions.30 The rate is 
also accelerated in the presence of heparin, a proxy for glycosaminoglycan (GAG) 
polysaccharides that are found associated with many different types of amyloid.30 
Interestingly, the GAG heparan sulfate prevented cytotoxic interactions of the G26R 
(Iowa) mutant with CHO cells.31 Thirdly, oxidation of methionine residues has been 
shown to accelerate fibril deposition at normal physiological pH.27, 28 Activated 
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macrophages in the atherosclerotic lesions secrete high levels of myeloperoxidase 
that oxidises apoA-I locally and reduces its anti-atherogenic function.32  
Although there are several X-ray and solution structures published for non-
aggregated apoA-I variants,8, 33, 34 high-resolution structural details of apoA-I fibrils 
are currently lacking.  It is not known whether the fibrils adopt a common structural 
architecture under the various conditions, or whether the structural plasticity of the 
protein results in diverse structural outcomes. In this work, we use high-resolution 
solid-state NMR and other methods to identify the structural features of aggregates 
formed by full-length, intact apoA-I and compare the structural composition of the 
aggregates formed at low pH, in the presence of heparin and after methionine 
oxidation.  
 
Experimental Methods 
ApoA-I expression 
Expression of N-terminally His-tagged apoA-I was carried out by following previously 
published methods.35, 36 A pNFXex expression vector coding for human apoA-I with 
an N-terminal His tag (kindly provided by Dr M. Oda, Oakland Research Institute, 
USA) was transformed into E. coli BL21 (DE3) cells (Agilent Technologies) and 
grown at 37°C in LB media containing 100 µg/ml ampicillin (Melford Laboratories). 
Once an OD600 of 0.6 was reached, protein expression was induced with 1 mM IPTG 
(Melford Laboratories) and incubated for 5 h. Transformed cells were also grown in 
minimal media incorporating 13C glucose and 15N ammonium chloride (99% purity, 
Cortecnet) as the sole carbon and nitrogen sources for analysis by solid-state NMR. 
Cells were harvested by centrifugation at 5,000 g for 20 minutes prior to re-
suspension in cell lysis buffer (6 M GnHCl, 20 mM NaH2PO4, 0.5 M NaCl, pH 7.4) 
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and sonication at 20 microns in cycles of 25 %, to avoid overheating. Cell debris was 
removed through centrifugation at 43,000 g for 30 minutes before loading onto a 20 
mL His Trap column (GE Healthcare) pre-equilibrated with lysis buffer. The column 
was washed with lysis buffer, binding buffer (20 mM NaH2PO4, 0.5 M NaCl pH 7.4) 
and binding buffer containing increasing concentrations of imidazole (25 mM and 50 
mM). ApoA-I was eluted with 20 mM NaPO4, 0.5 M NaCl, 500 mM imidazole and 
collected in 1 mL fractions. Fractions containing the highest protein content, 
measured by their absorbance at 260/280 nm, were pooled and dialysed against 4 L 
Tris buffer (20 mM Tris, 1 mM benzamidine, 1 mM EDTA pH 7) overnight. The 
protein was filtered using 0.2 µM filters (Corning) to remove any precipitate that 
formed during dialysis.  
To facilitate removal of an N-terminal affinity tag used in protein isolation, the 
plasmid DNA contained a Glu2Asp mutation linker sequence NH2-D
1DPPQS- with 
an acid-labile Asp2-Pro3 bond. The expressed protein was treated with 45 % formic 
acid at 55 °C for 5 hours to remove the His-tag by cleavage of the peptide bond 
between Asp-2 and Pro-3. Thus the protein lacks the native Glu-1 and Asp-2 
residues. Two rounds of dialysis against Tris buffer were then carried out to remove 
the excess formic acid prior to dialysis against McIlvaine Buffer (165 mM Na2HPO4, 
17.6 mM citrate, pH 7) and storage at -20 °C. The intact mass of apoA-I was 
confirmed by ESI mass spectrometry using a Waters Q-ToF micro system at a flow 
rate of 250 µL/hour via a syringe. The observed mass of 27,837 Da was in good 
agreement the expected mass of 27,834 Da. 
Oxidation methods  
ApoA-I was dialysed into 10 mM NaH2PO4 pH 7.5 overnight, prior to 
incubation with excess H2O2 (1000 fold molar excess) overnight at 37 °C. The 
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sample was then dialysed back into 10 mM NaH2PO4 pH 7.5 twice in order to 
remove any excess hydrogen peroxide.  
Thioflavin T fluorescence and sedimentation measurements 
Amyloid formation as measured by the enhancement of ThT (Sigma) 
fluorescence was carried out by a continuous read method, in which ThT was 
present during aggregation, and by a final read method in which ThT was added 
after a defined period. For continuous read, apoA-I (at 7 µM) was incubated in a 96-
well clear-bottomed plate with agitation in McIlvaine buffer with 20 µM ThT in a total 
volume of 200 µL. Some solutions contained heparin (IdoA(2S)-GlcNS(6S) 14-15 
kDa, >70 %, Iduron) at a twice the molar ratio to apoA-I.  Fluorescence 
measurements were taken in triplicate using a Molecular Devices Flexstation 3 plate 
reader with excitation at 430 nm and emission at 480 nm every 30 seconds for 10 
minutes, 2.5 µL of concentrated HCl was added to reduce the pH in wells that 
required a buffer of pH 4. Measurements were then taken every 30 seconds for 5 
hours to monitor aggregation.  
For the final read methods, apoA-I (36 µM) was incubated at pH 4 and pH 7 in 
the presence or absence of heparin. After 3 days’ incubation, the sample was added 
to a 96-well plate along with 20 µM ThT and an end point fluorescence measurement 
taken with excitation at 430 nm and emission 480 nm. The samples were then 
removed from the plate and centrifuged at 13,400 rpm for 5 minutes in a bench-top 
centrifuge to pellet any aggregated material. The fluorescence of the supernatant 
was then measured. All measurements were performed in triplicate. 
In experiments paralleling the final-read ThT measurements, apoA-I samples 
prepared under the same conditions but without ThT were centrifuged in a bench-top 
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centrifuge to sediment any aggregated material. The concentration of the protein 
remaining in the supernatant was measured using a Nanodrop 2000 (Thermo 
Scientific) and used to estimate the percentage of insoluble protein material.  
Transmission Electron Microscopy  
ApoA-I (36 µM) at pH 4, in the absence or presence of heparin (72 µM), was 
incubated at 37 °C for 3 days with agitation. Samples were pelleted and washed 
several times with distilled water to remove any buffer salts. Samples were diluted to 
18 µM before 10 µL was loaded onto carbon coated copper grids and left for 2 
minutes before excess sample was removed via blotting. The grid was then stained 
by inverting it onto a droplet of 0.2 % uranyl acetate. After 30 seconds of staining the 
grids were blotted and left to dry for 1 hour. The sample was then visualised on a 
Tecnai 10 electron microscope at 100 kV.  
Atomic Force Microscopy 
ApoA-I (36 µM) at pH 4, in the absence or presence of heparin at 72 µM, was 
incubated at 37 °C for 3 days with agitation. Samples were diluted to 18 µM and 
loaded onto freshly cleaved Mica surfaces and left to adhere to the membrane 
overnight. Samples were then washed with distilled water to remove any buffer salts. 
AFM was performed with a Keysight Technologies (Santa Rosa, Ca, USA) 5500 
series instrument fitted with a 90x90 µm scanner. All images were acquired in 
acoustic alternating contact (AAC or “tapping”) mode using etched silicon probes 
(PPP-NCL, Keysight) with nominal fundamental resonance frequencies of 190 kHz.  
These 225 µm-long cantilevers have a nominal force constant (k) of 48 N/m and a 
top height of 10-15 nm and a tip radius of <10 nm. PicoView (V1.2, Keysight) was 
used to control the AFM and capture the images. Height (topographic), amplitude 
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and phase shift images were recorded simultaneously over an area of 0.5 x 0.5 µm 
at a frequency of 160 kHz,a scan rate of 0.5 lines/sec a setpoint (Asp) of 2.2 V. 
Analysis of images was performed using the Gwyddian V2.44 software. 
Circular dichroism  
ApoA-I (72 µM) at pH 7 and pH 4, in the absence and presence of heparin 
(144 µM), was incubated at 37 °C with agitation. It was necessary to use a higher 
concentration than in the analyses by other techniques to improve sensitivity, 
because a short path length (0.1 cm) cuvette was required to minimize interference 
from the buffer at wavelengths below 200 nm. Samples were taken at 0, 1 and 2 
hour intervals and centrifuged at 13,400 rpm in a bench top centrifuge to pellet any 
insoluble material. The concentration of the supernatant was measured before 
loading into quartz cuvettes. SRCD experiments were performed between 185 and 
260 nm, with a wavelength increment of 1 nm, using a nitrogen flushed Module X 
end-station spectrophotometer and the data analysed using CDApps 37 at B23 
Synchrotron Radiation CD Beam line at the Diamond Light Source, Oxfordshire UK. 
Fitting was performed using the CONTINLL algorithm with dataset SMP 56 
containing SP43 and 13 membrane proteins between the wavelengths of 190 and 
250 nm. Samples of aggregated apoA-I formed at pH 4 in the absence and presence 
of heparin, from the solution circular dichroism experiments after 5 hours, were 
pelleted through centrifugation, deposited on Suprasil type quartz plates and dried 
under a stream of nitrogen at 23 °C to form a thin film. CD spectra were acquired 
between 180 and 260 nm using an integration time of 1 second and a bandwidth of 
1.2 nm on a nitrogen flushed module B end-station spectrophotometer at B23 
Synchrotron radiation CD beam line at Diamond Light Source, Oxfordshire UK. All 
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spectra presented are in the wavelength ranges that were unaffected by buffer 
interference and vary from sample to sample. 
Thermal stability CD measurements were carried out using a ChiraScan Plus 
bench-top spectropolarimeter (Applied Photophysics) equipped with a quantium 
northwest temperature control.   A temperature ramp from 20-90°C increasing at 1 
degree per minute was applied and the temperature was held whilst the scan was 
taken from 180-260 nm. In all cases, background signals were removed from the 
spectra by subtraction of the appropriate spectrum of the buffer (+/- heparin) only.   
X-ray diffraction  
ApoA-I (36 µM) at pH 4, both in the absence and presence of heparin (72 µM), was 
incubated at 37 °C with agitation for 3 days. The fibrils were pelleted through 
centrifugation at 5,000 rpm into a glass capillary using a bench top centrifuge. The 
sample was irradiated using a Cu-Kα radiation (1.54 Å wavelength) and images were 
collected using a CCD detector (Atlas-S2).  
Intrinsic fluorescence 
ApoA-I at 18 µM at pH 4 and pH 7, in the absence and presence of heparin (36 µM), 
were incubated at 37 °C with agitation. Fluorescence spectra from 300 to 400 nm 
were collected on a Cary Eclipse spectrometer, with excitation at 279 nm and a band 
pass of 1 nm, immediately and 1 hour after preparation of the samples.  
Sample preparation for solid-state NMR  
Uniformly 13C- and 15N-labelled apoA-I (36 µM) was incubated for 3 days at pH 4 in 
the absence or presence of heparin (2:1 ratio of heparin to Apo AI). The fibrils were 
then pelleted by centrifugation at 13,400 rpm for 5 minutes and frozen using liquid 
nitrogen. The pellets were centrifuged into zirconium 3.2 mm NMR rotors fitted with 
Kel-F caps (Bruker, UK). In order to compare the spectra of insoluble fibrils with the 
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spectrum of native, soluble protein, uniformly labelled apoA-I was freshly prepared in 
pH 7 McIlvaine buffer and lyophilised before transferring into a 3.2 mm rotor. 
Solid-state NMR methods 
One dimensional proton-decoupled 15N CP-MAS NMR experiments were performed 
at 25 °C using a Bruker Avance 400 MHz spectrometer (operating at a magnetic field 
of 9.3 T) equipped with a 3.2 mm HXY MAS probe.  Hartmann-Hahn cross-
polarization was achieved at a proton nutation frequency of 78 kHz with a contact 
times of 2 ms, 100 kHz proton decoupling with SPINAL-648 during signal acquisition 
and a recycle delay of 2 ms. Magic angle spinning was controlled at a frequency of 8 
kHz +/- 1 Hz. Each spectrum was the result of accumulating 20,000-100,000 
transients. Two dimensional 13C-13C spectra were recorded at 16.3 T with a 3.2 mm 
HXY probe operating in double-resonance mode and magic-angle spinning at 14 
kHz. Samples were cooled to 4 °C. Hartmann-Hahn cross-polarization was achieved 
with a 2-ms contact time and 100-kHz proton decoupling with SPINAL-64 was 
applied during signal acquisition. For broadband dipolar recoupling, spectra were 
recorded with a 10-ms mixing time during which the proton nutation frequency was 
adjusted to the MAS frequency of 14 kHz to meet the dipolar-assisted rotational 
resonance (DARR) condition.10 The time domain matrix was the result of 400 t1 
increments, each averaged over between 128 and 320 transients. Phase-sensitivity 
was achieved using the States-TPPI method. For selective dipolar recoupling, the 
proton nutation frequency was set to 100 kHz during a mixing time of 1-15 ms and 
the spinning frequency was adjusted to match the frequency difference of the nuclei 
to be recoupled.  
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Computational modelling 
Homology modelling was carried out using Modeller version 9.13 and docking 
experiments were carried out using Molsoft ICM-Pro v 3.8-4a. Both methods used as 
the template the structural model of ∆(185-243)apoA-I. For docking analysis, a dp8 
structural model of heparin previously reported 38 was used as the ligand. The initial 
docking region was defined by selection of the three histidine residues (H133, H153 
and H160). Docking runs were performed with the histidine residues of MAβ40 in the 
default charge state (as generated by conversion of pdb files in ICM-Pro), and 
repeated with all histidines positively charged (HIP).  Upon completion of docking 
hydrogen bonding interacions between ligand and receptor were observed. 
 
Results 
Heparin promotes the formation of amyloid-like apoA-I fibrils. 
ApoA-I aggregation after incubation at 37°C with agitation for 3 days was 
monitored by end-point addition of the amyloid-diagnostic fluorescent dye thioflavin T 
(ThT) and also by quantifying the remaining protein following sedimentation and 
removal of insoluble material.  ApoA-I aggregation is pH-dependent and both the 
yield of insoluble protein and ThT fluorescence increases with increasing acidity, with 
virtually no soluble protein remaining at pH 4 after 3 days (Figure S1A).   However, 
transmission electron microscopy (TEM) reveals that the protein aggregates are non-
fibrillar (Figure S1B).  The ability of full-length de-lipidated apoA-I to form non-
specific aggregates has long been known39 and is probably a result of isoelectric 
precipitation around the native protein’s pI of 5.17 (pI = 5.33 for the protein here, 
lacking the N-terminal Glu and Asp residues). 
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  Glycosaminoglycan polysaccharides are believed to influence the 
accumulation and degradation of amyloid in vivo. These extracellular matrix 
components are well known to co-localize with amyloid, confer protease resistance 
on the amyloid deposits and enhance the rate of amyloid assembly.40 The effect of 
GAGs on the rate of ApoA-I aggregation and on the aggregate morphology is here 
examined in the presence of 15 kDa heparin, a widely used proxy for cellular GAGs 
such as heparin sulfate.41 A 2-fold molar excess of heparin has no additional effect 
on the amount of insoluble material produced after 3 days over a pH 4-8  range, 
compared to the protein alone (Figure 1A). By contrast, when apoA-I is incubated 
with heparin at pH 6 or lower, addition of ThT after 3 days results in a large 
additional enhancement of fluorescence, as compared to the protein in the absence 
of heparin (Figure 1B).  The additional enhancement in the presence of heparin is 
not observed at pH 7 and pH 8, suggesting that heparin does not interact with the 
protein at neutral or mildly basic pH. It has been shown previously that heparin does 
not bind to apoA-I at neutral pH,42 possibly because apoA-I lacks protonated 
histidine binding sites for the polyanion.  
Continuous-read fluorescence measurements to monitor the time-course of 
aggregation in the presence of ThT confirms that apoA-I is stable at pH 7 with 
virtually no change in ThT fluorescence in the presence of heparin (data not 
presented). By contrast, addition of defined concentrations of heparin to the protein 
at pH 4 results in a rapid and immediate increase of ThT fluorescence in proportion 
to heparin concentration, followed by a slower exponential increase in fluorescence 
consistent with secondary nucleation catalysed by the surfaces of the rapidly-formed 
aggregates (Figure 1C).43  The initial enhancement is reduced systematically with 
increasing salt concentration, indicative of an electrostatic interaction between 
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heparin and the protein (Figure S2).  The rapid ThT increase is not consistent with 
stochastic nucleation of amyloid self-assembly, which is typically characterized by a 
lag-phase preceding rapid elongation, but implies that heparin promotes and directs 
the initial stages of protein self-assembly. The heparin concentration dependence of 
the initial fluorescence increase in Figure 1C could be fitted with a Hill equation 
giving an apparent dissociation constant (kD) for heparin of 7.8 µM at pH 4. A similar 
effect of heparin is observed when stable solutions of protein and different 
concentrations of heparin at pH 7 are rapidly acidified by the addition of a calibrated 
volume of HCl (Figure S3), giving an apparent kD of the same order of magnitude 
(2.6 µM).  
TEM reveals the deposition of fine (<10 nm width) fibrillar structures at pH 4 in 
the presence of heparin, which are not observed in the absence of heparin (Figure 
1D, left). Atomic force microscopy (AFM) also reveals networks of thin, amyloid-like 
fibrillar or protofibrillar species (Figure 1B, right). Taken together, these data suggest 
that heparin enhances the rate of formation and amyloid characteristics of apoA-I 
aggregates, but does not affect the final yield of insoluble material.   
Different apoA-I aggregation pathways in the absence and presence of heparin. 
The structural pathway of apoA-I aggregation was investigated by synchrotron 
radiation circular dichroism (SRCD).44, 45 The SRCD spectrum of a fresh apoA-I 
solution at pH 7 is consistent with the high degree of α-helical structure (>50 %) of 
the native folded protein observed previously by far-UV CD 46 (Table 1), with 
characteristic minima at 208 nm and 222 nm. Subsequent spectra show that this 
structure remains stable for up to 5 h (Figure 2A). At pH 4, although a considerable 
amount of protein precipitation occurred, the remaining diluted solution of the protein 
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still retained significant amount of α-helical structure even after 2 h  (insoluble 
material was removed by centrifugation before analysis) (Figure 2B).  Fitting of the 
spectrum suggests a partial loss of helical content and gain in β-sheet and 
disordered elements (Table 1).  In the presence of a 2-fold molar excess of heparin 
the intensity reduces considerably and it is no longer possible to discern the minima 
at 208 nm and 222 nm, although the signal-to-noise is now rather poor (Figure 2C). 
The solution spectra reflect only the structure of apoA-I remaining in the soluble form 
and do not report on the structure of the precipitated protein. We therefore isolated 
(by sedimentation and washing) the precipitated protein formed at pH 4 and obtained 
spectra of dried films of the precipitates only (Figure 3D). In the absence of heparin 
the spectrum is dominated by the typical α-helical features, but in the presence of 
heparin the minimum at ~222 nm is red-shifted to around 226 nm and the minimum 
at 208 nm reduces in intensity.  Differential SRCD spectrum obtained by subtracting 
out the SRCD spectrum with heparin to that without heparin gave an indication of 
presence of >40% β-strand component using the CONTINLL algorithm (Figure 2D). 
47 Further analysis using the BestSel algorithm 48 suggests the presence of β-strand 
of anti-parallel type. Virtually identical effects were observed for apoA-I aggregates 
formed after myeloperoxidase-catalysed oxidation of the methionine residues and 
these were attributed to increased β-sheet content.27  
Intrinsic fluorescence of tryptophans 8, 50, 72 and 108 (Figure 3A) provided 
further details of the structural rearrangements accompanying apoA-I aggregation.  
At pH 7 in the presence or absence of heparin, the emission maximum occurs close 
to 337 nm in fresh solutions and after 2 h the maximum wavelength remains 
unchanged despite a loss of overall emission intensity, which may reflect some 
protein precipitation (Figure 3, B and C). Similar emission maxima are observed at 
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pH 4 in the absence of heparin, although the intensity reduction is considerably 
greater after 2 h, consistent with more rapid precipitation at the lower pH (Figure 3, 
D). In the presence of heparin the initial intensity is much lower than under the other 
conditions and suggests rapid protein precipitation followed by a slower rate over the 
subsequent 2 h (Figure 3E).  A small blue shift to 335 nm occurs at pH 4 in the 
presence of heparin, which is not seen in the absence of heparin at pH 4 or when 
heparin is present at pH 7. The protein may undergo different structural 
rearrangements at pH 4 with heparin, which changes the environment(s) of one or 
more Trp residues. Typically, a blue shift indicates movement to a less polar 
environment and may also indicate movement of the fluorophore with respect to the 
positions of acidic and/or basic residues.49 In the crystal structure of the C-terminally 
truncated variant ∆(185-243)apoA-I, tryptophans 6, 48 and 70 are close to arginine 
residues (59, 25 and 8, respectively) and a cation-π interaction between K23 and 
W50 is also observed. One or more of these interactions may be disrupted at pH 4 in 
the presence of heparin.  
Heparin-catalysed ApoA-I fibrils comprise α-helical and β-sheet structural elements. 
Cross-polarization magic-angle spinning (CP-MAS) solid-state NMR (SSNMR) 
is a powerful technique for resolving atomic details of amyloid fibrils 50, but so far it 
has not been applied to apoA-I fibrils. Here we used SSNMR to analyse in further 
detail the structure of the insoluble, uniformly 15N- and 13C-labelled apoA-I fibrils 
formed with heparin at pH 4. Spectra were obtained from hydrated insoluble fibrils 
after incubation for 3 days and compared with the SSNMR spectra of soluble protein 
at pH 7 after lyophilization.  Chemical shifts for backbone 15N and amide carbonyl 
(C’), Cα and Cβ positions are sensitive markers of local secondary structure. The 
backbone 15N chemical shifts for the pH 7 sample are centred at ~119 ppm and 
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agrees with a simulated spectrum with chemical shifts predicted from the structure of 
∆(185-243)apoA-I 8, 51 (Figure 4A, top).  The spectrum is thus consistent with the 50-
60 % α-helical content 46 of the natively-folded protein.  The spectrum of fibrils 
formed at pH 4 in the presence of heparin is centred at ~121 ppm (Figure 4A, 
bottom), which indicates some structural perturbation from the α-helical-rich state. 
Amide 15N chemical shifts for β-sheet and random coils are typically higher than the 
corresponding shifts for α-helical structures.52 
Detailed structural differences between fibrillar and lyophilized protein are 
more evident when comparing two-dimensional 13C-13C SSNMR spectra of the two 
protein samples.  Both spectra have rather broad lines (particularly for the lyophilized 
sample), consistent with a higher degree of heterogeneity than is seen in 
morphologically pure fibrils (e.g., Ref. 53). This feature of the spectra, together with 
extensive peak overlap (a consequence of the size of the protein), prevented a full 
sequential assignment at this stage.  The resolution was nevertheless sufficient to 
observe cross-peaks from several amino acid types (see below). The spectrum of 
the lyophilized protein again agrees well with a simulated spectrum based on 
predicted Cα, Cβ and backbone amide carbon (C’) chemical shifts calculated from 
the crystal structure of ∆(185-243) apoA-I (Figure 4, B and C, left hand panels), and 
suggests that the protein retains predominantly its native helical structure after 
lyophilization. It should be recalled that here we are examining the full-length protein 
(except for residues 1-2) and so the spectrum also contains signal contributions from 
residues 185-243, which are absent from the crystal structure.8  This region 
constitutes the lipid binding domain and is conformationally-variable, alternating 
between exposed disordered and more stable helical conformations depending on 
the association with lipids.9 The readily-assigned Thr and Ser Cα-Cβ region of the 
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13C-13C spectrum may offer some insight into the structure of the C-terminal region. If 
the C-terminal region is unordered, well-resolved cross peaks for residues Thr-197, 
200, 237 and 242 and residues Ser-201, 204, 224 and 228 would be expected 
around 61/71 ppm and 57/65 ppm respectively.52 These are not evident in the 
spectrum. Cross-peaks for these residues in α-helical regions typically occur closer 
to the diagonal at 66/68 ppm and 61.63 ppm.52  It is possible, therefore, that the C-
terminal region adopts a partially α-helical conformation encompassing these 
residues, reflected in models presented elsewhere.33   
The spectrum of the fibrillar protein at pH 4 (Figure 4, B and C, right hand 
panels) features several pronounced differences from that of the lyophilized protein, 
notably the appearance of several additional cross peaks for Ala, Val, Leu, Ser and 
Thr residues. One set of cross-peaks for these amino acids coincide with those for 
the lyophilized native protein, but the second set of cross-peaks occur at chemical 
shifts that are typical of local β-sheet conformations.52 The Cα-Cβ cross-peaks occur 
at approximately 50.1-22.2 ppm for Ala (mean values of 50.9-21.7 ppm observed for 
β-sheet), 59.7-34.5 ppm for Val (60.7-33.8 ppm), 53.0-45.2 ppm for Leu (53.9-44.0 
ppm), 55.7-65.2 ppm for Ser (57.1-65.4 ppm) and 60.3-70.1 ppm for Thr (61.1-70.8 
ppm). Similar duplication of other cross-peaks may also occur, but could not be 
resolved.  It appears that, unusually for amyloid-like fibrils, apoA-I comprises both 
secondary structural elements and the relative contour integrals suggest that at least 
40 % of the above amino acids reside in β-sheet structures, although such 
quantitative analysis should be treated with caution. All five amino acids identified 
are distributed across the entire protein sequence, however, and so it is not possible 
to ascribe the β-sheet structures to a precise region of the protein. 
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ApoA-I residues 46-49 form β-sheet rich fibrils independently of heparin 
Previous work identified a highly amyloidogenic N-terminal peptide fragment 
of apoA-I comprising residues L49LDNWDSVTSTFSK (ApoA-I(46-59)).22 This 
sequence partially spans the unstructured region from Leu-40 to Thr-54 observed in 
the crystal structure of ∆(185-243)apoA-I.8 We investigated whether heparin 
promotes self-assembly of this peptide, to establish whether the corresponding 
sequence in full-length apoA-I could form an interaction site for heparin. Coulomb 
repulsion between the two Asp residues of the peptide and the anionic sulfate and 
carboxylate groups of heparin may be negated by ionic interactions with the cationic 
C-terminal lysine and a possible array of hydrogen bonding interactions with polar 
residues along the peptide chain. The presence of hydrogen-bonding residues 
alongside lysine and arginine has been posited recently as being a characteristic 
feature of GAG binding sites in proteins.54  Here, synthetic apoA-I(46-59) readily 
formed amyloid-like fibrils (~10 nm width) in the absence of heparin (Figure 5A) and 
SRCD revealed a concomitant structural rearrangement from mainly unordered to β-
sheet after four hours incubation at 25 °C (Figure 5B).  The minimum-to-maximum 
intensity transition around 194 nm after peptide aggregation is consistent with a 
conformational switch from an initial unfolded state to a predominantly β-sheet 
structure.    A natural abundance 13C SSNMR spectrum of unlabelled fibrils in the α-
carbon region, which is sensitive to secondary structure, agrees well with a 
simulated spectrum for a peptide β-sheet and is inconsistent with other structures 
(Figure 5C and Figure S4).  Peptide aggregation produces a rapid and large 
enhancement of ThT fluorescence, but, crucially, addition of a 2-fold excess of 
heparin does not have an appreciable effect on the rate of aggregation or on the 
apparent yield of fibrils as assessed by the end-point ThT fluorescence (Figure 5D). 
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These data indicate that although residues 46-59 are highly amyloidogenic and so 
may contribute to the self-assembly of apoA-I in the presence of heparin, they do not 
alone constitute a binding site for the GAG.   
Methionine oxidized apoA-I fibrils are similar to heparin-induced fibrils.  
   Structural analysis of ApoA-I fibrils formed at low pH is relevant because apoA-I 
deposits accumulate under pro-inflammatory conditions that are associated with 
local acidification of the extracellular environment. The pH within plaques is 
heterogeneous and ranges from 7.5 to 5.555. Nevertheless, the pathological pH is 
higher than the pH 4 conditions in which we observe apoA-I aggregation here.    It 
has been shown that myeloperoxidase-catalysed oxidation by H2O2/Cl
- and enzyme-
free chemical oxidation of apoA-I by H2O2 alone both modify methionine residues 
and accelerate the production of fibrillar amyloid within the atheromatous pH 
range.27, 28  Activated macrophages in the atherosclerotic lesions secrete high levels 
of myeloperoxidase that oxidize apoA-I methionine residues and reduce anti-
atherogenic function.32  Here we incubated apoA-I in solution at pH 7 with a large 
molar excess (1000:1) of H2O2 to selectively oxidize methionine residues.
30 SDS-
PAGE analysis confirmed that the protein remained intact after peroxide treatment 
(Figure 6A) and electrospray ionization (ESI) mass spectrometry indicated an 
increase in mass consistent with the oxidation of all three methionine residues (Met- 
86,112 and 148). CD measurements reveal differences in the thermal stability of 
unmodified and oxidized apoA-I (Figure S5). The unmodified protein undergoes a 
major structural change at around 56°C (Figure 6B), and qualitative analysis of the 
spectra suggest that partial unfolding of the predominantly α-helical structure occurs 
around this temperature, characterized by a shift in the CD minimum to 205 nm and 
loss of intensity around 222 nm (Figure 6C). The oxidized protein is much less stable 
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and undergoes major structural transitions at ~32°C and 70°C (Figure 6D). 
Qualitative analysis of the spectra indicates that below 32°C the protein retains its 
native, predominantly α-helical structure and between 32°C and 70°C the protein is 
in a partially unfolded state, (Figure 6E). Above 70°C the spectra are consistent with 
the protein regaining a partial helical structure.  The secondary structural content 
could not be estimated reliably because it was not possible to determine the amount 
of protein precipitation during the thermal ramp. 
The oxidized protein was incubated at pH 6 as described in previous work 27, 
28 and readily and rapidly formed a visible white precipitate in the absence of 
heparin, whereas no such insoluble material was observed for non-oxidized protein 
under the same conditions. TEM revealed a mixture of long fibrillar structures (~10-
20 nm width) and smaller spherical elements, possibly oligomers and/or protofibrils 
(Figure 7A). The 13C-13C spectrum of 13C-labelled apoA-I aggregates produced 
under these oxidative conditions is highly similar to the spectrum of aggregates 
formed by unmodified protein in the presence of heparin (Figure 7B). Both spectra 
share the same characteristic cross-peaks for α-helical and β-sheet structures. It 
appears that apoA-I aggregation resulting from interactions with heparin at pH 4 or 
methionine oxidation at pH 6, involve the same core changes to the native protein 
structure.      
 
Discussion 
The current understanding of the aggregation of ApoA-I into amyloid in vivo is that 
the process results in the deposition of N-terminal fragments of apoA-I, 80-100 
amino acids in length, and/or the full-length apoA-I. Familial apoA-I amyloidosis 
occurs when N-terminal fragments of mutant apoA-I species become deposited 
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within major organs,14, 16, 18, 27, 56 whilst acquired amyloidosis is linked to the 
deposition of full-length amyloid within atherosclerotic plaques.26, 30 The precise 
composition of the plaques and nature of the apoA-I species in atherosclerosis is 
only just coming to light.  
Here we report the first detailed structural investigation of wild-type apoA-I 
aggregation under pro-inflammatory conditions.  ApoA-I alone readily forms 
unordered aggregates in acidic medium, but in the presence of heparin at pH 4 the 
aggregation pathway is modified, resulting in short, ordered fibrillar structures giving 
the typical cross-beta diffraction spacings of amyloid. Surprisingly, the aggregates 
comprise both α-helical and β-sheet elements as revealed by solid-state NMR.  
Methionine oxidation results in longer ordered fibrils are formed alongside smaller 
spherical structures. Remarkably, despite the differences in the nanoscale 
morphologies of the heparin-promoted aggregates and the oxidized protein 
aggregates, their solid-state NMR spectra are virtually identical and consistent with 
the same structural features at the atomic level. What is not clear at this stage is 
whether the α- and β-structures represent entities that are structurally distinct (α-
helical oligomers/protofibrils and β-sheet rich fibrils being one simplified example) or 
entities that are identical at the atomic level and comprising both structural elements 
within the single protein fold. We argue that the latter proposition is more likely: if 
structurally distinct aggregates were formed then one would expect their populations 
to vary under the different conditions of aggregation. The characteristic SSNMR 
peaks for the two secondary structures (which correspond approximately to their 
populations) are in the same proportions regardless of whether the aggregates are 
promoted at pH 4 by heparin at pH 4 or at pH 6 after protein oxidation. Similarly, their 
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proportions do not vary when heparin-induced aggregation is carried out at pH 5 or 
at a lower protein concentration of 18 µM (data not shown). 
Louros and co-workers,57 and Das and co-workers,58 predicted three N-terminal 
amyloid-prone segments, residues 14-22, 53-58, 69-72, which in the native fold form 
an α-helical cluster, and the C-terminal residues 227-232.  Structural perturbations in 
the amyloid-prone segments, induced by natural mutations associated with familial 
apoA-I amyloidosis, have been proposed to trigger a structural conversion in the N-
terminal ~75 residues to form an intermolecular parallel β-sheet.58 The positions of 
most naturally-occurring mutation sites, when mapped onto the crystal structure of 
the truncated protein ∆(185-243)apoA-I, support this model.8, 19 Some mutations may 
initially cause only small perturbations in the native structure of the soluble protein, 
and it is subtle changes in attractive and repulsive side-chain interactions that 
appear to ultimately destabilize the protein, perhaps reducing the effect of residues 
protecting the major amyloid hot spot 14–22.56, 58  It has been postulated that the 
sequence E76KETEG act as a β-sheet breaker and, further, that protonation of the 
Glu residues under acidic pro-inflammatory conditions reduces this property and 
facilitates propagation of the β-sheet zipper from the N- to the C-terminus.58 
Although this process would reconcile all four amyloid hot spots in the full-length 
apoA-I, and expose the aggregates to protease cleavage, the SSNMR data clearly 
show that the fibrils retain an α-helical core and so do not support this hypothesis. 
How do the diverse processes of methionine oxidation and heparin binding 
trigger the formation of ordered fibrils sharing a common structure? The mechanism 
of amyloid formation after methionine oxidation was discussed previously and the 
increased polarity of methionine sulfoxide probably disturbs the helix bundle packing 
and reduces structural stability in a similar way to non-polar to polar mutations L60R, 
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L64R and L178H.58 Oxidation of Met-86 increased the amyloidogenic potential of the 
protein of destabilization27 and this residue interacts with the predicted amyloid 
hotspot residues 14-22.58  Oxidation could result in steric or electronic clashes with 
Tyr-16 promoting destabilization of the N-terminal helix.  ApoA-I has a 
preponderance of basic residues free to participate in charge interactions with the 
polyanionic sulfate and carboxylate groups of heparin.  The reduced effect of heparin 
around neutral pH suggests that protonated histidines may play a role in GAG 
binding.  Three of the four histidines of apoA-I, His-135, 155 and 162, occur in the 
third extended helix, and we speculate that these residues, together with 
neighbouring Arg and Lys residues, promote heparin binding to the external surface 
presented by helices 2 and 3 (Figure S6).  
In summary, apoA-I has a high propensity to aggregate at low pH, but 
interactions with GAGs of the extracellular matrix, or oxidation of methionine 
residues, are necessary to produce ordered fibrillar structures bearing the hallmarks 
of amyloid. SSNMR has revealed interesting and surprising new insights into the 
misfolding and amyloid formation of apoA-I, in particular that the amyloid species 
retain a high α-helical content. At present we can only apply these observations to 
apoA-I associated with acquired amyloidosis, but SSNMR may be used in future 
work to reveal similarities and/or differences in the aggregation pathways of the 
various apoA-I mutants associated with hereditary amyloidosis. 
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Table 1. Summary of apoA-I secondary content calculated from SRCD spectra of 
protein solutions.  
Conditions Time 
(h) 
Percentage secondary structurea 
  helix β-sheet turn unordered 
pH 7  0 65 8 13 14 
 2 62 9 24 5 
pH 7 + heparin 0 60 8 21 11 
 2 65 9 14 12 
pH 4  0 53 5 18 24 
 2 61 16 21 2 
pH 4 + heparinb 0 4 41 22 32 
 2 19 8 16 57 
a All normalised mean residual standard deviation (NMRSD) < 0.03 except where 
indicated. The estimation was carried out using CONTINLL 47 algorithm in the 
CDApps suite of programs 37. 
b NMRSD = 0.6 for pH 4 + heparin.   
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Figure 1. Enhancement of apoA-I aggregation by heparin. A: pH-dependence of 
insoluble protein formed after 3 days in the absence and presence of heparin (2-fold 
molar excess). B: pH-dependence of aggregation in the presence or absence of 
heparin measured by ThT fluorescence. C: Time-course of apoA-I aggregation at pH 
4 (7 µM).  All samples in figures A-C were for 10 minutes prior to addition of heparin 
(arrow). Mean and standard errors are shown in A, B and C for 3 samples per point. 
D: TEM (left) and AFM (right) characterization of apoA-I aggregates formed at pH 4 
in the presence of heparin (2:1 molar ratio) after incubation for 3 days.  
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Figure 2. SRCD spectra of apoA-I (72 µM) in the absence or presence of heparin (2-
fold molar excess). A: Spectra of apoA-I solutions at pH 7 in the absence of heparin, 
recorded after centrifugation to remove insoluble material.  B: Spectra at pH 4 in the 
absence of heparin. C: Spectra at pH 4 in the presence of heparin.  Dotted lines 
represent the best fits to the data using the CONTINLL algorithm. D: Spectra of dried 
films produced from apoA-I aggregates formed at pH 4 in the absence of heparin or 
with a 2-fold molar excess of heparin. 
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Figure 3. Time-dependence over 2 h of the intrinsic fluorescence emission of the four 
native apoA-I tryptophan residues. A: Structural model of residues 3-184 of natively 
folded monomeric apoA-I based on the crystal structure of the ∆(185-243)apoA-I 
domain-swapped dimer 8.  B: Spectrum at pH 7 alone.  C: Spectrum at pH 7 with a 2-
fold excess heparin. D: Spectrum at pH 4 alone.  E: Spectrum at pH 4 with a 2-fold 
excess of heparin. 
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Figure 4.  CP-MAS SSNMR spectra of apoA-I fibrils. Spectra were obtained for non-
aggregated protein after lyophilization from a pH 7 solution and from a concentrated 
hydrated precipitate formed after 3 days of incubation at pH 4 in the presence of a 2-
fold excess of heparin. The initial protein concentration was 36 µM in both cases.    
A: Backbone amide region of 15N spectra. B: Amide region of 2D 13C-13C spectra. C: 
High-field region of the 13C-13C spectra. The annotation of some cross-peaks with α 
and β refer to assignments of the corresponding residues in α-helical and β-sheet 
conformations.  Red lines and contours represent simulated spectra based on the 
model derived from the ∆(184-243)apoA-I structure 8 and were calculated from 
chemical shifts predicted by SHIFTX2 51. 
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Figure 5. Aggregation of the apoA-I (46-59) peptide (1 mg/ml at pH 4). A: TEM image 
showing amyloid fibrils formed after 3 days. B: SRCD spectra of the peptide in 
solution initially (black) and after incubation at 25°C for 4 h with shaking (red). C: 13C 
CP-MAS SSNMR spectrum of fibrils formed after 3 days. D: Thioflavin T 
fluorescence of the peptide alone and in the presence of a 2-fold excess of heparin.   
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Figure 6. Characterization of soluble oxidized apoA-I. A: SDS-PAGE gel of apoA-I 
before and after oxidization by treatment with hydrogen peroxide. B: The thermal 
stability of unmodified apoA-I (72 µM) at pH 7 determined by CD. The fractional 
composition of two apoA-I species was determined by deconvolution of the CD 
spectra. C: CD spectra representing the principal components present below (black) 
and above (red) the transition temperature of 56°C.  D: CD analysis of the thermal 
stability of oxidized apoA-I (72 µM) at pH 7 showing the fractional composition of 
three oxidized apoA-I species. E: CD spectra representing the principal components 
present below 32°C (black), between 32°C and 70°C (red) and above (blue) 70°C. 
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Figure 7. Characterization of insoluble oxidized apoA-I aggregates. A: TEM image of 
aggregates formed at pH 6 after apoA-I oxidation.  B: Superimposed 2D 13C-13C 
SSNMR spectra of unmodified apoA-I aggregates formed at pH 4 in the presence of 
heparin (black) and oxidized apoA-I aggregates formed at pH 6 in the absence of 
heparin (blue). 
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Heparin and methionine oxidation promote the formation of 
apolipoprotein A-I amyloid comprising -helical and -sheet 
structures. 
 
David Townsend, Eleri Hughes, Rohanah Hussain, Giuliano Siligardi, Sarah Baldock, 
Jillian Madine and David A. Middleton* 
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